Hülya Yazıcı

1.3k total citations
64 papers, 935 citations indexed

About

Hülya Yazıcı is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Hülya Yazıcı has authored 64 papers receiving a total of 935 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 17 papers in Genetics and 17 papers in Cancer Research. Recurrent topics in Hülya Yazıcı's work include BRCA gene mutations in cancer (14 papers), Epigenetics and DNA Methylation (9 papers) and MicroRNA in disease regulation (8 papers). Hülya Yazıcı is often cited by papers focused on BRCA gene mutations in cancer (14 papers), Epigenetics and DNA Methylation (9 papers) and MicroRNA in disease regulation (8 papers). Hülya Yazıcı collaborates with scholars based in Türkiye, United States and Canada. Hülya Yazıcı's co-authors include Nejat Dalay, Regina M. Santella, Hui‐Chen Wu, Mary Beth Terry, Yoon Hee Cho, S Yurdakul, C G Barnes, Karina González, A. Akinci and Huri Özdoğan and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Hülya Yazıcı

59 papers receiving 890 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hülya Yazıcı Türkiye	18	447	224	207	197	119	64	935
Monica Chang United States	17	311 0.7×	206 0.9×	68 0.3×	355 1.8×	449 3.8×	25	1.7k
Steve Nicholson United Kingdom	16	361 0.8×	330 1.5×	89 0.4×	40 0.2×	109 0.9×	34	994
HG Ahuja United States	12	409 0.9×	458 2.0×	145 0.7×	81 0.4×	64 0.5×	22	1.1k
A-L Børresen Norway	13	360 0.8×	416 1.9×	183 0.9×	122 0.6×	27 0.2×	13	760
Jill Hagenkord United States	19	380 0.9×	216 1.0×	336 1.6×	168 0.9×	16 0.1×	32	985
S. Fakharzadeh United States	5	607 1.4×	544 2.4×	114 0.6×	97 0.5×	51 0.4×	10	1.1k
Valérie Bonadona France	12	414 0.9×	460 2.1×	326 1.6×	343 1.7×	14 0.1×	38	1.0k
Douglas W. Sborov United States	20	559 1.3×	602 2.7×	92 0.4×	129 0.7×	14 0.1×	118	1.2k
Hildur Helgadóttir Sweden	19	593 1.3×	537 2.4×	184 0.9×	107 0.5×	11 0.1×	64	1.3k
Stephen S. Roberts United States	20	508 1.1×	382 1.7×	303 1.5×	88 0.4×	21 0.2×	73	1.3k

Countries citing papers authored by Hülya Yazıcı

Since Specialization

Citations

This map shows the geographic impact of Hülya Yazıcı's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hülya Yazıcı with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hülya Yazıcı more than expected).

Fields of papers citing papers by Hülya Yazıcı

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hülya Yazıcı. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hülya Yazıcı. The network helps show where Hülya Yazıcı may publish in the future.

Co-authorship network of co-authors of Hülya Yazıcı

This figure shows the co-authorship network connecting the top 25 collaborators of Hülya Yazıcı. A scholar is included among the top collaborators of Hülya Yazıcı based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hülya Yazıcı. Hülya Yazıcı is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tarakçı, Ela, Hülya Yılmaz, Özgür Duygulu, et al.. (2025). New insights of cerium oxide nanoparticles in head and neck cancer treatment. Scientific Reports. 15(1). 7665–7665. 2 indexed citations

Özkan, Mine, et al.. (2024). Factors associated with psychological distress during genetic counseling in high-risk women with breast cancer in Turkey. Supportive Care in Cancer. 32(6).

Çelik, Betül, et al.. (2024). Germline mutational variants of Turkish ovarian cancer patients suspected of Hereditary Breast and Ovarian Cancer (HBOC) by next-generation sequencing. Pathology - Research and Practice. 254. 155075–155075. 1 indexed citations

Ağaoğlu, Nihat Buğra, Özden Hatırnaz Ng, Ebru Zemheri, et al.. (2024). Managing CDH1 Cancer Risks in a Child: Complex Decision Making in a Family With Hereditary Diffuse Gastric Cancer. American Journal of Medical Genetics Part A. 197(2). e63897–e63897.

Çelik, Betül, et al.. (2023). DNA methylation of KIFC1 gene in determination of histological diagnosis, prognosis and metastasis of lung cancer. Pathology - Research and Practice. 249. 154742–154742. 3 indexed citations

Çelik, Betül, et al.. (2022). Evaluation of BRCA1/2 gene mutations in patients with high-risk breast and/or ovarian cancer in Turkey. SHILAP Revista de lepidopterología. 47(5). 588–594. 4 indexed citations

Saip, Pınar, et al.. (2021). New biomarkers in peripheral blood of patients with ovarian cancer: high expression levels of miR-16-5p, miR-17-5p, and miR-638. Archives of Gynecology and Obstetrics. 305(1). 193–201. 20 indexed citations

Çelik, Betül, et al.. (2020). Genome‑wide methylation profiles in monozygotic twins with discordance for ovarian carcinoma. Oncology Letters. 20(6). 1–1. 7 indexed citations

Çelik, Betül, et al.. (2020). FGFR4 c.1162G > A (p.Gly388Arg) Polymorphism Analysis in Turkish Patients with Retinoblastoma. Journal of Oncology. 2020. 1–8. 3 indexed citations

10.

Seven, Memnun, Lisa Shah, Sandra Daack‐Hirsch, & Hülya Yazıcı. (2020). Experiences of BRCA1/2 Gene Mutation–Positive Women With Cancer in Communicating Genetic Risk to Their Relatives. Cancer Nursing. 44(3). E142–E150. 16 indexed citations

11.

Kebudi, Rejin, et al.. (2019). Investigation of new candidate genes in retinoblastoma using the TruSight One “clinical exome” gene panel. Molecular Genetics & Genomic Medicine. 7(8). e785–e785. 7 indexed citations

12.

Bılır, Ayhan, et al.. (2019). Methylation Changes of Primary Tumors, Monolayer, and Spheroid Tissue Culture Environments in Malignant Melanoma and Breast Carcinoma. BioMed Research International. 2019. 1–9. 7 indexed citations

13.

Kebudi, Rejin, Samuray Tuncer, Meena Upadhyaya, et al.. (2007). A novel mutation in the NF1 gene in two siblings with neurofibromatosis type 1 and bilateral optic pathway glioma. Pediatric Blood & Cancer. 50(3). 713–715. 7 indexed citations

14.

Yazıcı, Hülya, et al.. (2003). Cyp17 genetic polymorphism in prostate cancer and benign prostatic hyperplasia.. PubMed. 113-114. 307–14. 18 indexed citations

15.

Yazıcı, Hülya, Musa Altun, Günter Hafız, & Nejat Dalay. (2001). Serum and Tissue c-erb B2, bcl-2, and Mutant p53 Oncoprotein Levels in Nasopharyngeal Cancer. Cancer Investigation. 19(8). 773–778. 1 indexed citations

16.

Yazıcı, Hülya, Kenan Dolapçıoğlu, Faruk Buyru, & Nejat Dalay. (2000). Utility of c-crbB-2 Expression in Tissue and Sera of Ovarian Cancer Patients. Cancer Investigation. 18(2). 110–114. 16 indexed citations

17.

Yazıcı, Hülya, Musa Altun, Canan Alatlı, Öner Doğan, & Nejat Dalay. (2000). c-erbB-2 Gene Amplification in Nasopharyngeal Carcinoma. Cancer Investigation. 18(1). 6–10. 24 indexed citations

18.

Yazıcı, Hülya, et al.. (1999). Bcl-2 gene rearrangements and apoptosis rates in patients with Non-Hodgkin’s lymphoma during chemotherapy. Clinical Biochemistry. 32(1). 45–49. 2 indexed citations

19.

Yazıcı, Hülya, Mahmut Müslümanoğlu, Deniz Güzey, et al.. (1996). Amplification in tumors and benign tissue of breast cancer patients. Cancer Letters. 107(2). 235–239. 6 indexed citations

20.

Saip, Sabahattin, et al.. (1993). P 039 Brainstem reflexes — Brainstem auditory evoked potentials and MRI in Behçet's syndrome. La Revue de Médecine Interne. 14. 72s–72s. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact